1
|
Furlan B, Časar Z, Šterk D, Fabris J. 3-Mercaptopropionic acid as a new reagent for the industrially applicable synthesis of highly pure O-desmethylvenlafaxine from venlafaxine. J Sulphur Chem 2014. [DOI: 10.1080/17415993.2014.964241] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- Borut Furlan
- Organic Synthesis Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, API Development, Kolodvorska 27, Mengeš 1234, Slovenia
| | - Zdenko Časar
- Organic Synthesis Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, API Development, Kolodvorska 27, Mengeš 1234, Slovenia
- Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, Ljubljana 1000, Slovenia
- Sandoz GmbH, Global Portfolio Management API, Biochemiestrasse 10, Kundl 6250, Austria
| | - Damjan Šterk
- Organic Synthesis Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, API Development, Kolodvorska 27, Mengeš 1234, Slovenia
| | - Jan Fabris
- Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, Ljubljana 1000, Slovenia
| |
Collapse
|
2
|
Belov AS, Vologzhanina AV, Novikov VV, Negrutska VV, Dubey IY, Mikhailova ZA, Lebed EG, Voloshin YZ. Synthesis of the first morpholine-containing iron(II) clathrochelates: A new class of efficient functionalized transcription inhibitors. Inorganica Chim Acta 2014. [DOI: 10.1016/j.ica.2014.06.016] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
3
|
O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P. Discovery of novel selective norepinephrine inhibitors: 1-(2-morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides (WYE-114152). J Med Chem 2011; 54:6824-31. [PMID: 21916421 DOI: 10.1021/jm200733r] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Sequential modification of the previously identified 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols led to the identification of a new series of 1-(2-morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides that are potent and selective inhibitors of the norepinephrine transporter over both the serotonin and dopamine transporters. One representative compound 10b (WYE-114152) had low nanomolar hNET potency (IC(50) = 15 nM) and good selectivity for hNET over hSERT (>430-fold) and hDAT (>548-fold). 10b was additionally bioavailable following oral dosing and demonstrated efficacy in rat models of acute, inflammatory, and neuropathic pain.
Collapse
Affiliation(s)
- David J O'Neill
- Chemical Sciences, Pfizer, 500 Arcola Road, Collegeville, Pennsylvania 19426, United States.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Belen’kii L, Gramenitskaya V, Evdokimenkova Y. The Literature of Heterocyclic Chemistry, Part X, 2005–2007. ADVANCES IN HETEROCYCLIC CHEMISTRY 2011. [DOI: 10.1016/b978-0-12-385464-3.00001-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
5
|
O’Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P. Discovery of Novel Selective Norepinephrine Reuptake Inhibitors: 4-[3-Aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231). J Med Chem 2010; 53:4511-21. [DOI: 10.1021/jm100053t] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | | | | | | | | | | | | | - Jim Harrison
- Neuroscience, PGRD, CN 8000, Princeton, New Jersey 08543
| | - Liza Leventhal
- Neuroscience, PGRD, CN 8000, Princeton, New Jersey 08543
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ. 1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors. J Med Chem 2010; 53:2051-62. [PMID: 20131864 DOI: 10.1021/jm901559e] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Efforts to identify new selective and potent norepinephrine reuptake inhibitors (NRIs) for multiple indications by structural modification of the previous 3-(arylamino)-3-phenylpropan-2-olamine scaffold led to the discovery of a novel series of 1-(indolin-1-yl)-1-phenyl-3-propan-2-olamines (9). Investigation of the structure-activity relationships revealed that small alkyl substitution at the C3 position of the indoline ring enhanced selectivity for the norepinephrine transporter (NET) over the serotonin transporter (SERT). Several compounds bearing a 3,3-dimethyl group on the indoline ring, 9k, 9o,p, and 9s,t, exhibited potent inhibition of NET (IC(50) = 2.7-6.5 nM) and excellent selectivity over both serotonin and dopamine transporters. The best example from this series, 9p, a potent and highly selective NRI, displayed oral efficacy in a telemetric rat model of ovariectomized-induced thermoregulatory dysfunction, a mouse p-phenylquinone (PPQ) model of acute visceral pain, and a rat spinal nerve ligation (SNL) model of neuropathic pain.
Collapse
Affiliation(s)
- An T Vu
- Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Alimardanov A, Gontcharov A, Nikitenko A, Chan AW, Ding Z, Ghosh M, Levent M, Raveendranath P, Ren J, Zhou M, Mahaney PE, McComas CC, Ashcroft J, Potoski JR. Large-Scale Synthesis of a Selective Inhibitor of the Norepinephrine Transporter: Mechanistic Aspects of Conversion of Indolinone Diol to Indolinone Aminoalcohol and Process Implications. Org Process Res Dev 2009. [DOI: 10.1021/op900141r] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Asaf Alimardanov
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Alexander Gontcharov
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Antonia Nikitenko
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Anita W. Chan
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Zhixian Ding
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Mousumi Ghosh
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Mahmut Levent
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Panolil Raveendranath
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Jianxin Ren
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Maotang Zhou
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Paige E. Mahaney
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Casey C. McComas
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - Joseph Ashcroft
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| | - John R. Potoski
- Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, U.S.A., and Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, U.S.A
| |
Collapse
|
8
|
Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template. Bioorg Med Chem Lett 2009; 19:4579-83. [PMID: 19616432 DOI: 10.1016/j.bmcl.2009.06.096] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2009] [Revised: 06/25/2009] [Accepted: 06/26/2009] [Indexed: 01/16/2023]
Abstract
Derivatives of N-[(3S)-pyrrolidin-3-yl]benzamides are disclosed as a new series of noradrenaline reuptake inhibitors (NRI). Structure-activity relationships established that potent NRI activity could be achieved by appropriate substitution at the 2-position of the phenyl ring; consequently, selective NRIs and dual NSRIs were prepared. Benzamide 11e was identified as a potent NRI with good selectivity over SRI and DRI, good in vitro metabolic stability, weak CYP inhibition and low affinity for ion channels. Evaluation in vivo, in rat microdialysis experiments, showed 11e increased noradrenaline levels by up to 350% confirming good CNS penetration. Benzamide 11e was differentiated from previous NRIs as it was significantly less lipophilic (DeltaclogP -0.9).
Collapse
|
9
|
Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors. Bioorg Med Chem Lett 2009; 19:2464-7. [DOI: 10.1016/j.bmcl.2009.03.054] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2009] [Revised: 03/10/2009] [Accepted: 03/12/2009] [Indexed: 10/21/2022]
|
10
|
Pontillo J, Wu D, Ching B, Hudson S, Genicot MJ, Gao Y, Ewing T, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS. Synthesis and structure–activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics. Bioorg Med Chem Lett 2008; 18:6151-5. [DOI: 10.1016/j.bmcl.2008.10.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2008] [Revised: 09/30/2008] [Accepted: 10/02/2008] [Indexed: 10/21/2022]
|
11
|
Structure–activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability. Bioorg Med Chem Lett 2008; 18:4491-4. [DOI: 10.1016/j.bmcl.2008.07.049] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2008] [Revised: 07/11/2008] [Accepted: 07/14/2008] [Indexed: 11/23/2022]
|
12
|
Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS. Synthesis and structure–activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint. Bioorg Med Chem Lett 2008; 18:4495-8. [DOI: 10.1016/j.bmcl.2008.07.050] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2008] [Revised: 07/11/2008] [Accepted: 07/14/2008] [Indexed: 11/25/2022]
|
13
|
Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS. Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI). Bioorg Med Chem Lett 2008; 18:4224-7. [DOI: 10.1016/j.bmcl.2008.05.057] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2008] [Revised: 05/12/2008] [Accepted: 05/15/2008] [Indexed: 12/01/2022]
|
14
|
Fish PV, Barta NS, Gray DLF, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA. Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity. Bioorg Med Chem Lett 2008; 18:4355-9. [PMID: 18621528 DOI: 10.1016/j.bmcl.2008.06.071] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2008] [Accepted: 06/23/2008] [Indexed: 01/16/2023]
Abstract
Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine are disclosed as a new series of noradrenaline reuptake inhibitors (NRI). Carboxamide 9e, carbamate 11b and sulfonamide 13a were identified as potent NRIs with excellent selectivity over SRI and DRI, good in vitro metabolic stability and weak CYP inhibition. Carbamate 11b demonstrated superior transit performance in MDCK-mdr1 cell lines with minimal P-gp efflux which was attributed to reduced HBA capacity of the carbamate group. Evaluation in vivo, in rat microdialysis experiments, showed 11b increased noradrenaline levels by 400% confirming good CNS penetration.
Collapse
Affiliation(s)
- Paul V Fish
- Discovery Chemistry, Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent CT13 9NJ, UK.
| | | | | | | | | | | | | |
Collapse
|
15
|
Fish PV, Ryckmans T, Stobie A, Wakenhut F. [4-(Phenoxy)pyridin-3-yl]methylamines: A new class of selective noradrenaline reuptake inhibitors. Bioorg Med Chem Lett 2008; 18:1795-8. [DOI: 10.1016/j.bmcl.2008.02.036] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2008] [Revised: 02/11/2008] [Accepted: 02/12/2008] [Indexed: 01/16/2023]
|
16
|
Design of Monoamine Reuptake Inhibitors: SSRIs, SNRIs and NRIs. TOPICS IN MEDICINAL CHEMISTRY 2008. [DOI: 10.1007/7355_2008_028] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
17
|
Chapter 2 Recent Developments in Monoamine Reuptake Inhibitors. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 2007. [DOI: 10.1016/s0065-7743(07)42002-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register]
|